We use cookies to store user preferences and to anonymously track visitors for analytics. Some cookies are essential and can't be turned off. If you would like to allow all cookies please click Accept otherwise click Decline to disable all but essential cookies. For more information please view our Privacy Policy.
Study findings suggest that PD patients of older age (mean 78.3 years) with longer disease duration (mean 12.7 years) are particularly susceptible to COVID-19 with a substantially high mortality rate (40%). Those on advanced therapies, such as deep brain stimulation or levodopa infusion therapy, seem specially vulnerable and a mortality rate of 50% among our four such cases is of concern.
Read more in Movement Disorders 2020 Jun. Vol. 35(6); 905-908
doi: 10.1002/mds.28104
Copyright © 2020 EPDA. All Rights Reserved
Back to top